Large-scale testing (Phase 3)UnknownNCT05204368
What this trial is testing
Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)
Who this might be right for
Complicated Urinary Tract Infection Including Acute Pyelonephritis
Evopoint Biosciences Inc. 780